A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia
Hämostaseologie · 01.12.2023 · 43 (06) · 426-431
DOI: 10.1055/a-2116-8957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.12.2023. Verfasst von Kaiqi Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Afibrinogenemia, Hemostatics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
Our study aimed to analyze the phenotype and genotype of a pedigree with inherited dysfibrinogenemia, and preliminarily elucidate the probable pathogenesis.
Methods
The one-stage clotting method was used to test the fibrinogen activity (FIB:C), whereas immunoturbidimetry was performed to quantify the fibrinogen antigen (FIB:Ag). Furthermore, DNA sequence analysis was conducted to confirm the site of mutation. Conservation analysis and protein model analysis were performed using online bioinformatics software.
Results
The FIB:C and FIB:Ag of the proband were 1.28 and 2.20 g/L, respectively. Gene analysis revealed a heterozygous c.293C > A (p.BβAla68Asp) mutation in FGB. Bioinformatics and modeling analysis suggested that the missense mutation could potentially have a deleterious effect on fibrinogen.
Conclusion
The BβAla68Asp mutation in exon 2 of FGB may account for the reduced FIB:C levels observed in the pedigree. To our knowledge, this point mutation is the first report in the world.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, Zhejiang, People's Republic of China.
Zitieren
APA
Jia, K., Zeng, M., Zheng, X., Xie, H., Yang, L., Xie, Y., & Wang, M. (2023). A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia. Hämostaseologie, 43(06), 426-431. https://doi.org/10.1055/a-2116-8957
Vancouver
Jia K, Zeng M, Zheng X, Xie H, Yang L, Xie Y, et al. A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia. Hämostaseologie. 2023;43(06):426-431. doi:10.1055/a-2116-8957
BibTeX
@article{Jia2023,
author = {Jia, Kaiqi and Zeng, Manlin and Zheng, Xiaoyong and Xie, Haixiao and Yang, Lihong and Xie, Yaosheng and Wang, Mingshan},
title = {A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia},
journal = {Hämostaseologie},
year = {2023},
volume = {43},
number = {06},
pages = {426--431},
doi = {10.1055/a-2116-8957}
}
EUVIMED